Research, development, production, and marketing of prescription drugs in four therapeutic areas: cardiovascular, renal & metabolism, oncology, respiratory & immunology, and rare diseases.
EmpCo Directive — September 27, 2026
We analyzed the websites of over 250,000 companies, including AstraZeneca's, to extract CSR initiatives and communications containing risky environmental claims.
Greenwashing risk score + your position within your sector
+250,000
Total organizations analyzedAnalysis by axis
Access the detailed report with all sector benchmarks, in-depth competitive analysis and actionable recommendations.
Methodology: Score calculated according to 6 CSR themes (Carbon, Biodiversity, Circular Economy, Sustainable Investments, Governance, Social Impact)
Sources: Public data, CSR reports, documented initiatives, official databases
Last update: July 2026
This analysis is not yet available in English. Please see the French version.
Leading organizations
Servier
A
Development and marketing of pharmaceutical products, with a focus on cardiology, venous diseases, oncology, and neurology. Investment in R&D for innovative and targeted therapeutic solutions.
Chiesi
B
Development and commercialization of pharmaceuticals for respiratory diseases, neonatology, transplantation, and rare diseases.
Sanofi
B
Development of innovative medicines and vaccines, focusing on therapeutic areas like rare diseases, neurology, immunology, oncology, diabetes, cardiovascular diseases, and consumer healthcare.
Initiatives identified among leaders
Réduction des émissions scope 3 validée par SBTi
“Servier vise une réduction de 66,3 % de ses émissi...” - ServierProgrammes de santé pour les communautés vulnérables
“Sanofi Pasteur met en place des programmes de sant...” - SanofiStructuration de la feuille de route et indicateurs pour la mission d’entreprise.
“En 2022, Chiesi a structuré sa feuille de route en...” - Chiesi64% of similar organizations communicate on CSR issues
+885 initiatives collected from 50 similar organizations
Is your score incomplete? Update your CSR information and improve your positioning.
Claim this page
Updated data
Personalized recommendations
Access complete data, competitive analyses and actionable recommendations for your clients.
Comprehensive sector benchmarks
Competitive data
Ready-to-use reports